Inherited retinal degenerations: clinical phenotypes and emerging therapies

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Inherited retinal degenerations (IRDs) encompass a wide spectrum of genetic disorders leading to progressive vision loss.
• Genetic testing reveals significant heterogeneity, with pathogenic variants identified in numerous genes.
• These conditions highlight the complex genetic and cellular processes underlying vision maintenance.

Purpose of the Study:

• To review the clinical presentation and classification of IRDs based on affected retinal cells.
• To summarize novel therapeutic strategies for IRDs.
• To emphasize the importance of early diagnosis and professional care for optimal visual outcomes.

Main Methods:

• Literature review of inherited retinal degenerations.
• Clinical classification based on primary retinal cell type affected.
• Summary of current and emerging treatment modalities.

Main Results:

• IRDs present diverse clinical features and are categorized by the primary retinal cell impacted.
• Novel treatments including gene therapy, cell therapy, optogenetics, and implantable chips show promise.
• Accurate diagnosis through genetic testing is crucial for effective management.

Conclusions:

• Understanding the genetic basis and clinical heterogeneity of IRDs is key.
• Emerging therapies offer new hope for patients with progressive vision loss.
• Timely referral to eye care professionals facilitates early diagnosis and improves visual prognosis.